Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in heightDaniel B. Hawcutt, Joanne Blair, Anne Povall et al.|PLoS ONE|2017Cited by 13
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part twoRachel Corkhill, Ольга Василівна Ломакіна, Е.I. Alexeeva et al.|Pediatric Rheumatology|2017Cited by 9